New findings are coming out on almost a weekly basis about trace elements of gadolinium left in human tissue after scans with MRI contrast agents. What do we know about this phenomenon, and how serious is it? We talk to Dr. Robert McDonald, PhD, of the Mayo Clinic in Rochester, MN.
Video Interview 2018 RSNAVideo from RSNA 2018: What do we know about gadolinium deposition?
Nov 26, 2018
Latest in MRI
Simulated contrast-enhanced MRI helps assess prostate cancer
January 15, 2025
ML model using CCTA, MRI data predicts MACE in cardiac patients
January 14, 2025
Genetic testing, risk assessment tied to more breast MRI uptake
January 13, 2025